AASTROM BIOSCIENCES, INC.

Will Shares Of Aastrom Really Triple From Today's Levels Within A Year?

Aastrom initiated with a Buy at Maxim

Needham & Company Initiates Coverag on Aastrom Biosciences (ASTM) at Buy; Late-Stage Cell Therapy Product Likely First to Market

Aastrom initiated with a Buy at Needham

Aastrom Biosciences to Present at World Stem Cells & Regenerative Medicine Congress

Ascendiant Capital Starts Aastrom Biosciences (ASTM) at Strong Buy; Leading Pure Play in Regenerative Medicine

Aastrom initiated with a Strong Buy at Ascendiant Capital

Aastrom reports Q1 EPS (25c) , consensus (20c)

Aastrom Biosciences Reports First Quarter 2012 Financial Results

Aastrom Biosciences Announces First Patient Enrolled in REVIVE Phase 3 Clinical Trial of Ixmyelocel